TAVR for Bicuspid, Tricuspid Aortic Valve Stenosis Confers Similar Outcomes Up to 1 Year (Healio)
Patients who underwent transcatheter aortic valve replacement had similar rates of stroke and all-cause mortality at 30 days and 1 year regardless of whether they had bicuspid or tricuspid aortic valve stenosis, researchers reported.
SCAI® is a registered trademark of the Society for Cardiovascular Angiography and Interventions.
All content found on the Society for Cardiovascular Angiography and Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.
Get in touch
1100 17th Street NW, Suite 400, Washington, DC 20036